Lactobacillus paracasei-derived extracellular vesicles alleviate neutrophilic asthma by inhibiting the JNK pathway in airway epithelium
Allergology International · 2024
DOI: 10.1016/j.alit.2023.10.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergology International, 2024. Verfasst von Soyoon Sim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, South Korea; Department of Biomedical Science, Graduate Sch…. Hauptthemen laut MEDLINE: Asthma, Extracellular Vesicles, Lacticaseibacillus paracasei. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Ministry of Health and Welfare, National Research Foundation of Korea.
Abstract (Originalsprache)
BACKGROUND: Lactobacillus paracasei has been known to reduce airway resistance and inflammation in asthma. However, the therapeutic effect of its extracellular vesicles (EVs) in patients with asthma remains unclear. METHODS: To validate the clinical relevance of L. paracasei-derived EVs (LpEV) in asthma, the composition of gut microbial EVs was verified by metagenomics in LPS-induced C57BL/6 mice. The components of proteins and metabolites in LpEV were identified by peptide mass fingerprinting and metabolomic analysis. The serum levels of specific IgG1 or IgG4 antibodies to LpEV were compared by ELISA between patients with eosinophilic asthma (EA, n = 10) and those with neutrophilic asthma (NA, n = 10) as well as with healthy controls (HCs, n = 10). Finally, therapeutic effects of LpEV and their metabolites in asthma were validated in vivo/in vitro. RESULTS: Significantly lower proportions of EVs derived from Lactobacillus at the genus level were noted in mice with NA than in control mice. Moreover, the serum levels of LpEV-specific IgG4, but not IgG1, were lower in patients with NA than in those with EA or in HCs and positively correlated with FEV1 (%) values. In addition, oral administration of LpEV reduced airway resistance and inflammation in mice with NA. Finally, LpEV and their 3 metabolites (dodecanoic acid, palmitoleic acid, and D-(-)-tagatose) significantly inhibited JNK phosphorylation/IL-8 production in airway epithelium in vitro. CONCLUSIONS: These findings suggest that LpEV may have a therapeutic potential targeting NA by suppressing the JNK pathway and proinflammatory cytokine production in airway epithelium.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, South Korea; Department of Biomedical Science, Graduate School of Ajou University, Suwon, South Korea.
- MD Healthcare Inc., Seoul, South Korea.
- Department of Biomaterials Science, College of Natural Resources and Life Science, Pusan National University, Miryang, South Korea. Electronic address: ychoi@pusan.ac.kr.
- Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, South Korea; Department of Biomedical Science, Graduate School of Ajou University, Suwon, South Korea. Electronic address: hspark…
Förderung
- Korea Ministry of Health and Welfare
- National Research Foundation of Korea
Zitieren
APA
Sim, S., Park, H. J., Kim, Y. K., Choi, Y., & Park, H. S. (2024). Lactobacillus paracasei-derived extracellular vesicles alleviate neutrophilic asthma by inhibiting the JNK pathway in airway epithelium. Allergology International. https://doi.org/10.1016/j.alit.2023.10.008
Vancouver
Sim S, Park HJ, Kim YK, Choi Y, Park HS. Lactobacillus paracasei-derived extracellular vesicles alleviate neutrophilic asthma by inhibiting the JNK pathway in airway epithelium. Allergology International. 2024. doi:10.1016/j.alit.2023.10.008
BibTeX
@article{Sim2024,
author = {Sim, Soyoon and Park, Hyeon Ju and Kim, Yoon-Keun and Choi, Youngwoo and Park, Hae-Sim},
title = {Lactobacillus paracasei-derived extracellular vesicles alleviate neutrophilic asthma by inhibiting the JNK pathway in airway epithelium},
journal = {Allergology International},
year = {2024},
doi = {10.1016/j.alit.2023.10.008}
}
EUVIMED